Volume-wise, France has been in the top 5 ODA donors over the past years. According to the DAC, ODA represented 0.43% of its GNI in 2017 (USD 11 billion in volume).
According to our methodology, France allocated USD 954 million to global health in 2016, which represented 0.042% of its GNI; far from the recommendation of the WHO Commission on Macroeconomics and Health, and below the performance of the UK.
We note a relatively good performance in 2014 (0.051% of GNI allocated to DAH) which was mainly due to a substantive loan to reform the health sector in Colombia. In 2015, the ratio decreased sharply and plummeted to its lowest level since 2007.
14.3% of overall ODA was dedicated to DAH (Development Assistance for Health)
in 2016. The ratio has been constantly decreasing since 2013.
The Global Fund to Fight AIDS, Tuberculosis and Malaria is the main recipient of multilateral ODA , followed by the European Union and UNITAID .
As a consequence of the massive loan allocated to Colombia in 2014, France has channelled the majority of its bilateral DAH to upper-middle-income countries: 59% in 2014 against 21% for lower-income countries. In 2015, the situation reversed: 32.5% was allotted to lower-income countries.
Since the CRS database does not allow providing multiple recipients for one activity, all the multi-countries or multi-regions projects are reported as “unspecified”.
It’s worth noting that in 2014, 11% of the projects were unallocable by income groups, up to 36% in 2015. This could bias the analysis.